New Hemp Magazine to Be Published By Hemp Inc. and Resource Ventures Inc.

Publishing & Media

Share Tweet

New Hemp Magazine to Be Published By Hemp Inc. and Resource Ventures Inc.

Does the recent legalization of hemp mean the world is now ready for a magazine on the subject?

Well, apparently Hemp Inc. (OTCPINK: HEMP) and Resource Ventures, Inc. (PINKSHEETS: REVI) think so.

On Feb. 12 in a joint statement Resource Ventures, Inc. and Hemp, Inc. announced they have entered into a joint venture to publish The Hemp Nation Magazine, however, no mention was made when the magazine’s first issue would hit the newsstands or be online.

Joint Venture

Pursuant to the terms of the JV Agreement, Hemp, Inc. said it will produce and edit all content for the industrial hemp magazine. REVI said it will bear responsibility for publishing the magazine. It is anticipated that hemp paper will be used for at least some of the material for publishing the magazine, including the cover.

Bruce Perlowin, CEO of Hemp, Inc., said, “We believe that there is a very good 'fit', both from a business and a personal perspective, between the parties.”

“This relationship opens Resource Ventures, Inc. to a whole world of possible joint ventures, mergers and acquisitions,” said Kimberly Kaiser, president of Resource Ventures Inc.

The release went on to say that the Industrial Hemp and Medical Marijuana Consulting Company, Inc. pulls industry information from a vast network of specialists that consists of other public industry, public companies' CEOs and networks of experts, bankers, investors, lawyers, other consultants, industry analysts, and non-profits connected to this industry as well as the traditional industry experts in all areas of the various business opportunities the industry presents.

According to the release, Perlowin, and his associates, have a wealth of knowledge and experience. This culmination of knowledge and experience has even attracted the attention of banks, which want in on the billions of dollars flowing through the public company sector of this industry.


More Exuberant Optimism on Hemp

Recently Hemp’s Perlowin expressed his exuberance about the legalization of hemp in a provision of the new Farm bill Congress passed and President Obama signed into law last week. 

“It’s an unbelievable moment in in the history of hemp,” Perlowin said, in a Feb. 10, 2014 interview on Bloomberg TV. “We are about to start a clean American Industrial Revolution.”

Perlowin added that the legalization of hemp would eventually generate billions of dollars.

The Las Vegas-based Hemp Inc. has already developed and is selling a wide portfolio of products made from industrial Hemp, including fabric, paper, insulation, plastics, cooking oil and even salad dressings.

Find out what could be the best investor’s move when it comes to HEMP by getting the complete report here, or by cutting and pasting the following link in your Web browser:

New Line of Vaporizer Products

Hemp Inc. is also developing vaporizers for the medical and recreational marijuana industry. 

On Jan. 28, VaporBrands International, Inc. (OTC Pink: VAPR) announced it has entered into a Letter of Intent to form a joint venture with Marijuana, Inc., a wholly owned subsidiary of Hemp.

Under terms of the proposed joint venture, Marijuana, Inc. will assist VaporBrands with the development and distribution of specialized marijuana vaporizing products to be sold primarily through existing medical marijuana dispensary networks.

In addition, VaporBrands and Marijuana, Inc. have agreed to research, develop and distribute vaporizer products specifically for the use of Hemp Oil in natural medicine. Marijuana, Inc. has also agreed to assist VaporBrands in expanding the retail distribution of its current and future electronic nicotine based cigarette products.

This latest move by HEMP through its subsidiary certainly strengthens its position in the marketplace. It also filled a much needed gap in its vertical offerings. While it’s too soon to measure how this will affect HEMP’s overall revenue, no one can deny it is a positive development – especially in light of the new farm bill.

On Feb. 12, Hemp’s stock volume soared to 191,614,520 shares, substantially more than its three-month average volume of 61,022,652 shares.

Hemp’s share value closed at 16 cents on Feb 12, up 1 cent, from its close of 15 cents the previous day.

Find out what could be the best investor’s move when it comes to HEMP by getting the complete report here, or by cutting and pasting the following link in your Web browser:


Two Strong Points

Colorado Springs, Colo-based Advanced Cannabis Solutions (OTCQB: CANN) has two strong practical points going for it: It's headquartered in the middle of one of the first, vibrant legal-marijuana marketplaces in the country and it's just been approved for a major line of credit.

These two elements are essential for the company to be able to build and equip the facilities it wants to rent to cannabis growers, which by the way, certainly fits the criteria of being a practical and promising product or service.

In Colorado alone, the medical marijuana market is estimated to be $350 million in size while the legalization of recreational marijuana could expand that figure to over $500 million in 2014 by some accounts. These figures are significantly larger throughout the United States. Some analysts estimate the total market at between $10 billion and $120 billion per year in size, depending on the success of various legalization efforts and the components included in the estimates.

Just Got New 30-Million Credit Line

On Jan. 21, Advanced Cannabis Solutions announced that it had established a $30-million credit line.

According to a release, Advanced Cannabis Solutions signed a definitive agreement with Full Circle Capital Corp., a closed-end investment company. The agreement provides that the investment fund will initially provide $7.5 million to the Company in the form of Senior Secured Convertible Notes, subject to certain conditions. An additional $22.5 million can be borrowed by Company with the mutual agreement of the Company and the investment company.

At least 95% of the loan proceeds will be used to acquire properties, which the company consistent with its business plan, will lease to licensed cannabis growers.

"The six-year loan will be secured by real estate acquired with the loan proceeds, and will require interest-only payments at a rate of 12% per year," the release explained, outlining the agreement.

On Feb 12, CANN's share price closed at $12.30, up 30 cents from its closing price of $12.05  the previous day.

Find out what could be the best investor's move when it comes to CANN by getting the complete report here, or by cutting and pasting the following link in your Web browser:


Still Riding the Hemp-Legalization Wave

The volume of Creative Edge Nutrition Inc.’s (OTC Pink: FITX) continued to spike on Feb. 12, with 90,066,060 shares changing hands, substantially higher than its three-month average of 88,011,933 shares.

The volume was sparked in part by the passage by Congress last week of a farm bill that for the first time legalizes the use of Hemp for research and farming. Many observers believe this is just the latest domino to fall in a line of dominos that will eventually come crashing down as the medical and recreational use of marijuana is legalized throughout the United States

Health Canada forecasts that there will be half a million medical marijuana  users in Canada in 10 years, but Creative Edge Nutrition Inc.’s (OTC Pink: FITX) CEO Bill Chaaban told Forbes Magazine Dec. 30 that with the availability and the assurance of consistency of the product it could  only take two years for users to reach that magnitude.

A Potential Windfall – Operative Word ‘Potential’

These forecasts point toward a potential windfall for Creative Edge and other companies like them, if the Canadian government grants the Michigan-based company the final approval to sell medical marijuana in the country.

On Jan. 9, Creative Edge inched closer to approval by complying with the Canadian government’s regulations on tracking 1.3 million pounds of medical marijuana annually. The medical marijuana is to be distributed by Creative Edge’s wholly owned subsidiary CEN Biotech.

Creative Edge cleared this obstacle by using a new state-of-the-art M3Hub Seed-to-Sale tracking platform, which meets and exceeds Health Canada's tracking compliance regulations. This news comes less than two months after Creative Edge broke ground on its new 58,000-square-foot future Medical Marijuana distribution center, which will be attached to the company’s current 26,400-square-foot facility.

On Feb. 12, FITX shares closed at 9 cents down 1 cent from its closing price of 8 cents the previous day.

Find out what could be the best investor’s move when it comes to FITX by getting the complete report here, or by cutting and pasting the following link in your Web browser:


Perfectly Positioned

Hollywood, Calif.-based Medbox, Inc. (OTCPINK Markets: MDBX), a maker of patented, self-service, identity-verifying medicine dispensers, believes it is perfectly positioned to cash in on the burgeoning medical marijuana market in California.

“Legal marijuana is one of the most rapidly expanding medical markets in the U.S., projected to exceed $3 billion in 2014," said Dr. Bruce Bedrick, chief executive officer, Medbox, Inc., in a written statement. “This rapid growth is creating significant opportunities and Medbox is positioned as the first mover and clear industry leader in this burgeoning sector. Our offerings include sophisticated and comprehensive consulting services for dispensary permit applicants and cultivators, as well as offering dispensing technologies and vaporizers. The breadth and depth of our offerings position us to strengthen our leadership role and we felt it was an appropriate time to retain proven IR counsel to help us raise our visibility in the investment community, communicate our investment thesis and broaden our shareholder base,” he added.

Medbox’s dispensers even have the precaution of requiring a finger print check for identity. The company hopes to ultimately place these dispensers in the thousands of clinics and approved facilities that it hopes one day will dispense medical marijuana.

New Patents Awarded

At the same time, Medbox is developing and patenting even more practical products for the cannabis industry.

On Jan. 21, Medbox announced that it has expanded its intellectual property portfolio with the confirmation that it has been awarded two additional patents for its Vaporfection brand of products. The announcement was made in conjunction with a comprehensive shareholder update, and Form 10 filing with the Securities and Exchange Commission.

The patents, awarded to the company's wholly owned subsidiary, Vaporfection International, Inc., specifically relate to:

  • Vapor Glass™ technology, which features the use of laboratory grade glass encased heating element positioned in the center of the laboratory grade glass heating chamber air pathway.  This unique Glass on Glass design results in a superior quality and efficient air/heat flow vapor, which ensures that nothing but the purest convection heated air enters the plant material, which releases the purest, naturally flavored and virtually odorless vapor into the users’ respiratory system. This method is unlike most vaporizers that apply conduction heat to the plant material using ceramics, metals and other possible contaminates in the air pathway.

·       Vapor Sense™ technology, which features a touch screen interface linked to an automatic temperature sensing control system. The technology uses a digital microprocessor temperature controller directly connected to a thermo coupling temperature sensor in the heating chamber. It also incorporates a fixed temperature setting option, auto shut-off, and cool-down safety features.


MDBX share price closed at $25.84 on Feb. 12, down $1.16 cents from its closing price of $27.00 the previous day.

Find out what could be the best investor’s move when it comes to MDBX by getting the complete report here, or by cutting and pasting the following link in your Web browser:

Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.